Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Coya Therapeutics, Inc.

NASDAQ: COYA · Life Sciences · 5 alerts · CIK 1835022

Share price
$3.00Close, Nov 16
Market cap
$70.4M
Shares outstanding
23.46MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Coya Therapeutics, Inc. filings on SEC EDGAR ↗

8:30 AM ET 8-K
Clinical Trial Data

Coya Therapeutics Clinical Trial Data

Coya Therapeutics announced it has achieved full enrollment of 120 patients in its Phase 2/3 ALSTARS trial evaluating COYA 302 for the treatment of amyotrophic lateral sclerosis (ALS). The company expects to release topline data from the double-blind treatment phase in early Q2 2027.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.